Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
PaperCitations, authors & open-access status
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 286 citations, 2022 year and hybrid oa status.
286
Citations
2022
Year
hybrid
OA Status